Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · May 10, 2022

Tumor Lysis Syndrome and Infectious Complications During Treatment With Venetoclax Plus Azacitidine or Decitabine in Patients With AML

Leukemia Research


Additional Info

Disclosure statements are available on the authors' profiles:

Leukemia Research
Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia
Leuk. Res 2022 Apr 25;117(xx)106844, S Arora, C Zainaldin, S Bathini, U Gupta, S Worth, K Bachiashvili, R Bhatia, K Godby, O Jamy, S Rangaraju, B Diamond, JD Oliver, D Salzman, A Di Stasi, P Vachhani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading